Takeaways: Nuvaxovid’s availability across 10 provinces and Yukon strengthens Sanofi’s position in Canada’s seasonal COVID-19 vaccine market by expanding access to a protein-based, non-mRN...
Browsing Tag: 2026-2027 respiratory season
Takeaways: Nuvaxovid’s availability across 10 provinces and Yukon strengthens Sanofi’s position in Canada’s seasonal COVID-19 vaccine market by expanding access to a protein-based, non-mRN...